NYSE
Artivion, Inc. (AORT)
♥ 605 Thanks from members
Artivion, Inc. (AORT) displays mixed sentiment and financial volatility in 2026, driven by double-digit revenue growth countered by widening GAAP net losses, lowered full-year guidance, and heavy reliance on expensive debt and earnouts to fund major strategic acquisitions like Endospan.